Medical Research News

RSS

Takeda to present data from three Hematology studies at WFH 2020

Takeda Pharmaceutical Company Limited, today announced a scientific update from the AHEAD real-world study investigating the long-term outcomes associated with ADVATE in patients with hemophilia A, presented as an oral presentation at the World Federation of Hemophilia Virtual Summit 2020.

From Takeda 17 Jun 2020

Even brief exposure to certain chemicals can prematurely age the liver epigenome

The epigenome is sometimes referred to as the "software" or "operating system" of the genome. It comprises small chemical modifications to DNA and the proteins that make up our chromosomes, and controls the activity of all the genes within the genome.

17 Jun 2020

Antipsychotic medications do not treat young people with early psychosis

Researchers at Orygen have found that some young people with early stage first episode psychosis (FEP) can experience reduced symptoms and improve functioning without antipsychotic medication when they are provided with psychological interventions and comprehensive case management.

17 Jun 2020

Neuroscientist discovers neuronal pulses in the human brain that activate after an injury

A neuroscientist's neon pink arm cast led him and fellow researchers at Washington University School of Medicine in St. Louis to discover previously undetected neuronal pulses in the human brain that activate after an immobilizing illness or injury.

17 Jun 2020

Researchers take actions to reduce hospitalizations and deaths from COVID-19

Infectious disease experts from Fred Hutchinson Cancer Research Center and UW Medicine are advocating for earlier actions to reduce hospitalizations and deaths from COVID-19.

17 Jun 2020

Nano-bio hybrid systems could deliver tumor therapy

Announcing a new article publication for BIO Integration journal. In this mini-review article the authors Yuhao Chen, Meng Du, Jinsui Yu, Lang Rao, Xiaoyuan Chen, and Zhiyi Chen from The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China and the National Institute of Biomedical Imaging and Bioengineering, Bethesda, MD, USA consider nanobiohybrids in cancer therapy.

17 Jun 2020

An improved tetravalent antibody blocks SARS-CoV-2 infection

A new study published on the preprint server bioRxiv* in June 2020 shows the potential of a new fusion molecule called a biparatopic protein to inhibit viral interaction with the host cell ACE2 receptor. This could lead to therapeutic applications.

17 Jun 2020

Scientists use fMRI to explain why people are still lonely even if they are around others

Social connection is essential to one's well-being, but how the brain reflects a person's attachment to other people remains unclear. Now, a team of researchers has found that loneliness can alter the brain's social network, explaining how the brain represents relationships.

17 Jun 2020

Researchers investigate how neural circuits enable the brain to regulate basal sighing

One group of neurons controls various types of sighing, but they receive their instructions from different areas of the brain depending on the reason for the sigh, according to a study scheduled to publish June 16 in the journal Cell Reports.

17 Jun 2020

Mapping RNA sequences of therapeutic value in the SARS-CoV-2 genome

Now, in new research published on the preprint server bioRxiv European scientists have performed RNA structure probing to obtain a single-base resolution secondary structure map of the full SARS-CoV-2 coronavirus genome.

17 Jun 2020

SARS-CoV-2 mutated spike proteins show variations in cell entry

A new study by Japanese scientists published on the preprint server bioRxiv* in June 2020 shows that the D614g mutation in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein can enhance the infectivity of the virus while leaving it vulnerable to neutralization by antibodies.

17 Jun 2020

Novel ACE2-antibody fusion molecules show anti-SARS-CoV-2 activity

Now, in a new study published on the preprint server, bioRxiv researchers in the U.S. investigated a soluble version of ACE2 for SARS-CoV-2 viral neutralization activity.

17 Jun 2020

Scientists isolate powerful SARS-CoV-2 -neutralizing antibodies from COVID-19 patients

A new study has shown that potent antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could help protect against COVID-19 infection. Preliminary results in animal studies have so far proven successful. The study titled, "Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model," was published in the latest issue of the journal Science.

17 Jun 2020

CSIRO study on the effects of COVID-19 on weight and well being

The CSIRO, Australia's federal government agency responsible for scientific research, has come up with a study looking at the emotional well being and weight loss or gain associated with the COVID-19 pandemic and the forced stay-at-home measures.

16 Jun 2020

Antibiotic X-206 effective against SARS-CoV-2 in vitro

The current study published on the preprint server bioRxiv aims to understand how these compounds affect SARS-CoV-2 in vitro. The researchers from Aarhus University in Denmark examined 11 natural PEIs, with a single synthetic analog, screening them for inhibitory activity against the CPE of SARS-CoV-2 infecting cultured cells with overexpression of TMPRSS2, a serine protease that is instrumental in cleaving the spike protein of the virus.

16 Jun 2020

Study: One in five adults experienced a decrease in their sexual behavior early in the pandemic

One in five adults in the United States report they have experienced change - mostly a decrease - in their sexual behavior during the early months of the COVID-19 pandemic, according to a new study by Indiana University researchers.

16 Jun 2020

How antibodies neutralize SARS-CoV-2 in convalescent patients

A new study by researchers from the United Kingdom and Taiwan and published on the preprint server bioRxiv in June 2020 describes the structural basis for the neutralizing effect of the SARS-CoV-2 antibody on the virus. This also indicates a possible therapeutic molecule by identifying its binding epitope as possibly a major neutralizing site.

16 Jun 2020

Medical Research News

Takeda to present data from three Hematology studies at WFH 2020

Even brief exposure to certain chemicals can prematurely age the liver epigenome

Antipsychotic medications do not treat young people with early psychosis

Neuroscientist discovers neuronal pulses in the human brain that activate after an injury

Researchers take actions to reduce hospitalizations and deaths from COVID-19

Nano-bio hybrid systems could deliver tumor therapy

An improved tetravalent antibody blocks SARS-CoV-2 infection

Scientists use fMRI to explain why people are still lonely even if they are around others

Researchers investigate how neural circuits enable the brain to regulate basal sighing

Mapping RNA sequences of therapeutic value in the SARS-CoV-2 genome

SARS-CoV-2 mutated spike proteins show variations in cell entry

Novel ACE2-antibody fusion molecules show anti-SARS-CoV-2 activity

Scientists isolate powerful SARS-CoV-2 -neutralizing antibodies from COVID-19 patients

CSIRO study on the effects of COVID-19 on weight and well being

Antibiotic X-206 effective against SARS-CoV-2 in vitro

Study: One in five adults experienced a decrease in their sexual behavior early in the pandemic

How antibodies neutralize SARS-CoV-2 in convalescent patients

Anti-TNF drug preserves beta-cell function in newly diagnosed pediatric patients with Type 1 diabetes

TERAVOLT tracks outcomes of people with thoracic cancers affected by COVID-19

Two potent small molecules appear to suppress tumor growth in multiple cancers

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News